HERAMED LIMITED (HMD) - Transforming Maternity Care: CEO Anoushka Gungadin on HeraCare, HeraBeat, and Innovative Health Solutions for Expectant Mothers

ASX BRIEFS

Send us a Text Message.

Curious about how the latest technology is transforming maternity care? Listen to our insightful conversation with Anoushka Gungadin, the Managing Director and CEO of HeraMED Limited. Anoushka unveils how HeraMED's flagship innovations, HeraCare and HeraBeat, are making prenatal and postpartum care more accessible and efficient. Discover how their proprietary heart rate monitor and comprehensive health platform are setting new standards by focusing on mum-centric care, in contrast to the traditional hospital-centric approach.
In this episode, Anoushka also discusses the incredible growth of the HeraCare platform, which now hosts a record number of active users, enabling the collection of invaluable data for predictive analytics and early detection. Learn about Heramed's strategic partnerships, including collaborations with the University of Technology Sydney and Broward Health, which are pivotal for their commercialization strategy and ongoing research and development. Whether you're an expectant mother, a healthcare provider, or just fascinated by cutting-edge medical technology, this episode is packed with insights you won't want to miss.